Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Banhabaekchulchonmatang is a traditional Korean herbal medicine (TKM) formulation primarily used for the treatment of tinnitus and dizziness. It is a multi-herb preparation that typically includes *Pinellia ternata*, *Atractylodes macrocephala*, and *Gastrodia elata*, among other botanical ingredients. In South Korea, it is approved as an herbal medication by the Ministry of Food and Drug Safety. The formulation is traditionally indicated for conditions associated with "phlegm-dampness," which in modern clinical terms often translates to vestibular and auditory symptoms. It has been evaluated in a randomized, double-blind, placebo-controlled Phase III clinical trial sponsored by the Korea Health Industry Development Institute (KHIDI) to determine its efficacy in adult patients with chronic tinnitus.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on banhabaekchulchonmatang.